when do glp 1 patents expire 8 key drug expiring soon — and what it means for the market Patents and regulatory exclusivities on

2.2 Why India Matters as a Market India has: Over 77 million people with diabetes A rapidly growing obese and overweight middle class This makes India not only a low-cost manufacturing base, but also a large end-consumption market for advanced metabolic therapies

Researchers are finding that GLP-1 agonists influence multiple pathways involved in inflammation, cardiovascular health, mood, motivation and rewardbenefits that appear to extend beyond the downstream effects of weight loss alone

Promoting a feeling of fullness: Incretin receptors in the brain get a signal that tells the body it has reached a state of fullness, which then leads the person to stop eating

You can find information about the specific data involved in this Privacy Policy